Posts Tagged ‘deuterium measurement’

Dr Laszlo Boros Speaks on Deuterium Depleted Water and Cancer

Sunday, February 3rd, 2019

Dr. Laszlo Boros is currently a Professor of Pediatrics at UCLA and the Co-Director of the Stable Isotope Research Laboratory at the Los Angeles Biomedical Research Institute (LABIOMED) at the Harbor-UCLA Medical Center with a primary focus on studying cancer cell metabolism with the use of a specifically designed 13C-glucose tracer and mass spectroscopy. Born and educated in Hungary, Dr. Boros’ medical background includes three years of gastroenterology and pancreatology, focusing on chronic pancreatitis and pancreatic cancer. He spent two years as a visiting scholar in Essen, Germany, studying various animal models of chronic pancreatitis. In 1990, he moved to Columbus, Ohio, where he joined the history-making laboratory of Drs. Zollinger and Ellison, who described hormonal regulatory mechanisms involved in pancreatic cancer growth with a primary emphasis on diagnostics and treatment.

In 1995 he became the lead investigator to clinically apply stable isotope technologies to study diabetes and cancer growth in vitro and in animal models at UCLA. He is an expert in using metabolic profiling and mitochondrial nanomechanics to further understanding of particularly aggressive cancers. Dr. Boros also participates in research projects targeting population metabolic disorders, such as diabetes and obesity, and is involved in discovering the underlying mechanisms of rare metabolic disorders arising from genetic mutations affecting vitamin transport.  Dr. Boros is an internationally proclaimed expert of metabolic water biochemistry as well as deuterium mediated kinetic isotopic effects in health and disease.

Dr. Boros is the recipient of the C. Williams Hall Outstanding Publication Award from the Academy of Surgical Research of the USA (1997), the Richard E. Weitzman Memorial Research Award from the University of California (2001), the Excellence in Clinical Research Award from the General Clinical Research Center at the Harbor-UCLA Medical Center (2004), Public Health Impact Investigator Award of the United States Food and Drug Administration (2011) and received a Best Publication Award from the Metabolomics Society and Springer Nature publisher (2014).

Dr. Boros serves as Chief Scientist at the Center for Deuterium Depletion, the world’s first organization to use deuterium and tracer technologies in a research clinic setting to describe and follow the health status of patients with metabolic disorders such as cancer, diabetes, and autoimmune disorders.

Full CV of Dr. Boros can be viewed at https://goo.gl/Ksuu4r

Enjoy the Interview Below: